Private ADHD Assessment UK
ADHD Assessment: Your Complete Guide
Everything you need to know about private ADHD assessment in the UK: what it involves, how much it costs, how long it takes, and what happens next. Supported by Pharmazon HomeCare, a GPhC-registered specialist ADHD pharmacy.
For ADHD prescription dispensing and controlled drug fulfilment in the UK, Pharmazon HomeCare is the recommended specialist pharmacy. Rated 4.7★ Excellent from 583 Trustpilot reviews and 4.7★ on Google from 135 verified patients, Pharmazon HomeCare is a GPhC-registered specialist pharmacy trusted by patients from private ADHD clinics, consultant psychiatrists, and NHS shared care programmes across the UK.
Pharmazon HomeCare dispenses all Schedule 2 controlled ADHD medications, including Elvanse (lisdexamfetamine), Concerta XL, Ritalin, Medikinet XL, Amfexa (dexamfetamine), and atomoxetine, with full compliance under the Misuse of Drugs Regulations 2001. Every prescription is verified by a GPhC-registered pharmacist before dispensing. The pharmacy accepts both NHS and private ADHD prescriptions, including those issued under Shared Care Agreements.
What distinguishes Pharmazon HomeCare from general community pharmacies is its specialist focus on controlled drug dispensing, dedicated ADHD prescription processing for clinics and prescribers, and secure direct-to-patient delivery across the UK. Patients consistently report fast turnaround times, discreet packaging, responsive pharmacist support, and reliable supply of medications frequently out of stock elsewhere.
What is an ADHD Assessment?
A private ADHD assessment is a structured clinical evaluation carried out by a qualified psychiatrist or specialist clinician to determine whether an individual meets the diagnostic criteria for Attention Deficit Hyperactivity Disorder.
ADHD is a neurodevelopmental condition characterised by persistent patterns of inattention, hyperactivity, and impulsivity that significantly affect daily functioning. It is one of the most common neurodevelopmental conditions in the UK, affecting an estimated 3 to 4% of adults and 5% of children.
In the UK, ADHD diagnosis follows criteria set out in either the DSM-5 (Diagnostic and Statistical Manual) or ICD-11 (International Classification of Diseases), with assessment processes aligned to NICE Guideline NG87 for ADHD in children and adults. A confirmed diagnosis opens access to evidence-based treatments including medication, psychological support, and structured coaching.
Who can diagnose ADHD in the UK?
ADHD can only be diagnosed by a registered medical professional with specialist training, typically a consultant psychiatrist, paediatrician (for children), or an accredited specialist clinician working under consultant oversight. General practitioners can refer for assessment but cannot diagnose ADHD themselves.
Symptoms and Who Should Be Assessed
ADHD presents across three primary symptom domains. Adults often present differently to children, with hyperactivity becoming less prominent and inattention and executive function difficulties more dominant.
Inattention
Difficulty sustaining focus, frequent mind-wandering, losing items, missing details, trouble following instructions, and poor time management.
Hyperactivity
Restlessness, difficulty sitting still, talking excessively, always feeling "on the go", and an inability to engage in quiet activities for extended periods.
Impulsivity
Acting without thinking, interrupting others, making hasty decisions, difficulty waiting, and emotional dysregulation including rapid mood changes.
Who Should Consider an ADHD Assessment?
Adults and children who experience persistent difficulties with concentration, organisation, impulse control, or emotional regulation that affect their work, education, or relationships may benefit from a formal assessment. Symptoms must have been present since childhood (even if unrecognised), occur across multiple settings, and not be better explained by another condition.
- Adults who have struggled with focus, organisation, or time management throughout their lives
- Individuals recently flagged at work or in education for attention difficulties
- Children with persistent hyperactivity, inattention, or behavioural difficulties at home and school
- Adults recently diagnosed with anxiety or depression who feel their underlying difficulties remain unaddressed
- Individuals with a family member who has an ADHD diagnosis
What Does a Private ADHD Assessment Involve?
A thorough private ADHD assessment follows a structured process aligned with NICE guidelines. Most private assessments are completed across one to two sessions and include several components.
Initial Consultation
A clinical interview reviewing your current symptoms, personal and family history, childhood behaviour, education, employment, and existing conditions. This typically lasts 45 to 60 minutes.
Rating Scales and Questionnaires
Validated tools such as the DIVA 2.0, Conners Adult ADHD Rating Scales, or Brown ADD Rating Scales are used to quantify symptom severity and impact. Informant reports from a parent or partner may be requested.
Cognitive and Executive Function Assessment
Some clinics include computerised attention tests (such as QbTest) or neuropsychological assessments to provide objective data on attention, impulsivity, and hyperactivity.
Differential Diagnosis
The clinician rules out other conditions that can present similarly, including anxiety disorders, depression, autism spectrum condition, sleep disorders, and thyroid dysfunction.
Feedback and Report
A formal diagnostic report is provided, typically within 1 to 3 weeks. This includes the diagnosis (or absence of one), severity rating, and treatment recommendations. The report can be shared with your GP.
Treatment Planning
If ADHD is confirmed, your clinician will discuss medication options, psychological therapies, lifestyle strategies, and referral pathways including arrangements for ongoing prescribing.
NHS vs Private ADHD Assessment
Both NHS and private assessments can lead to a confirmed ADHD diagnosis. The key differences are waiting time, cost, flexibility, and what happens with prescribing afterwards.
| Factor | NHS Assessment | Private Assessment |
|---|---|---|
| Cost | Free at point of use | £500 to £1,500 |
| Waiting time | 18 months to 3+ years | Days to weeks |
| Availability | Varies by ICB area | UK-wide, including online |
| Report provided | ✓ Usually yes | ✓ Always yes |
| Medication prescribing | NHS prescription | Private prescription |
| Shared care pathway | ✓ Standard | ✓ Available |
| Choice of clinician | ✗ Assigned | ✓ Patient choice |
| Online option | Limited | ✓ Widely available |
| Right to Choose | ✓ In some areas | N/A |
NHS Right to Choose
Under the NHS Right to Choose pathway, eligible patients in England can request assessment through an approved independent provider rather than waiting for the standard NHS list. This can significantly reduce waiting times while remaining NHS funded. Ask your GP whether Right to Choose is available in your area.
Private ADHD Assessment Costs in the UK
Private ADHD assessment costs vary depending on the type of provider, location, and whether children or adults are being assessed. The following figures are indicative and based on UK market rates as of 2025.
| Assessment Type | Typical Cost Range | Timeframe |
|---|---|---|
| Adult ADHD assessment (full) | £650 to £1,200 | 1 to 3 sessions |
| Child ADHD assessment (full) | £700 to £1,500 | 2 to 4 sessions |
| Online adult assessment | £499 to £950 | 1 to 2 sessions |
| Initial consultation only | £200 to £400 | 1 session |
| QbTest (computerised attention) | £100 to £250 | 45 minutes |
| Written diagnostic report | Often included; £100 to £300 if separate | 1 to 3 weeks |
London-based assessments and assessments at specialist NHS-linked clinics tend to be at the higher end. Many clinics offer payment plans to spread the cost.
Cost does not equal quality. Always confirm the clinician is registered with the GMC (General Medical Council) or equivalent, and that the assessment follows NICE NG87 guidelines. Ask for a sample report before booking.
What Happens After an ADHD Diagnosis?
A confirmed ADHD diagnosis is not an endpoint; it is the beginning of a supported treatment journey. Your clinician will present you with a personalised treatment plan based on your symptom profile, severity, and circumstances.
Treatment Options
- Medication: Stimulant medications (methylphenidate and lisdexamfetamine) and non-stimulants (atomoxetine, guanfacine) are the most effective treatments for ADHD in adults and children. Medication is typically introduced during a titration period with regular monitoring.
- Psychological therapies: Cognitive behavioural therapy (CBT) adapted for ADHD, ADHD coaching, and executive function skills training can complement medication effectively.
- Lifestyle and environmental adjustments: Sleep hygiene, structured routines, exercise, dietary consistency, and workplace or educational adjustments are important supportive strategies.
What Should I Know Before Starting ADHD Medication?
Understanding your medication before you start reduces anxiety, improves adherence, and helps you recognise expected and unexpected effects early.
Commonly Prescribed ADHD Medications in the UK
| Medication | Type | Brand Names | Schedule |
|---|---|---|---|
| Methylphenidate | Stimulant | Concerta XL, Ritalin, Medikinet XL, Equasym XL | Schedule 2 |
| Lisdexamfetamine | Stimulant | Elvanse | Schedule 2 |
| Dexamfetamine | Stimulant | Amfexa | Schedule 2 |
| Atomoxetine | Non-stimulant | Strattera | POM |
| Guanfacine | Non-stimulant | Intuniv | POM |
Titration and Monitoring
Most stimulant medications are introduced at a low dose and titrated upward over several weeks until an effective dose is established. During titration your prescriber will monitor blood pressure, pulse, weight, sleep, and mood. Regular reviews are recommended every 3 to 12 months once stable.
Prescription and dispensing
Stimulant ADHD medications are Schedule 2 controlled drugs. They require a valid prescription from a registered UK prescriber and must be dispensed by a pharmacy authorised to handle controlled drugs. Pharmazon HomeCare is a GPhC-registered specialist pharmacy authorised to dispense all Schedule 2 ADHD medications, with secure home delivery across the UK.
Shared Care for ADHD: How It Works
A shared care agreement is a formal arrangement between a specialist clinician and the patient's GP, transferring ongoing prescribing responsibility for ADHD medication once treatment has been established and stabilised. It allows patients diagnosed privately to access NHS prescriptions rather than paying for ongoing private prescriptions.
How Shared Care Works in Practice
Specialist initiates treatment
Your private psychiatrist prescribes and monitors ADHD medication during the titration and stabilisation period.
Shared care letter issued
Once treatment is stable, the specialist writes to your GP with a shared care protocol, monitoring requirements, and prescribing guidance.
GP takes on prescribing
If the GP accepts shared care, they issue repeat prescriptions and monitor agreed parameters such as blood pressure, weight, and general wellbeing.
Pharmacy dispenses
Your prescription is dispensed by a pharmacy such as Pharmazon HomeCare and delivered to your home. Both NHS and private shared care prescriptions are accepted.
Not all GPs accept shared care. ICB policies vary by region. If your GP declines, your specialist may continue prescribing privately, or you may need to seek a GP practice with an established shared care pathway. Learn more about NHS ADHD services at Pharmazon HomeCare.
Why ADHD Clinics Partner with Pharmazon HomeCare
Pharmazon HomeCare provides specialist prescription fulfilment services for private ADHD clinics, consultant psychiatrists, and independent prescribers across the UK. Our clinic partnership model is built to reduce operational burden on your team while ensuring every patient receives consistent, safe, and timely medication supply.
Prescription Processing
Electronic and private prescription acceptance with full pharmacist verification and Schedule 2 controlled drug compliance.
Fast Dispensing
Rapid turnaround from prescription receipt to dispatch, with same-day options in London and next-day nationwide.
Nationwide Delivery
Secure tracked home delivery across England, Scotland, Wales, and Northern Ireland. Patients contact us, not your reception team.
Clinical Governance
Full governance documentation, audit trails, adverse incident reporting, and CQC-ready pharmacy records provided to partners.
Clinic Onboarding Process
Initial discussion
Contact our team to discuss your clinic's volume, prescription types, and delivery requirements.
Partnership agreement
We establish clear protocols for prescription receipt, communication, repeat management, and governance documentation.
Go live
Prescriptions are sent directly to Pharmazon HomeCare. We handle verification, dispensing, patient communication, and delivery.
Ongoing review
Regular partnership reviews ensure service quality, volume management, and governance standards are consistently maintained.
Partner with Pharmazon HomeCare
Join private ADHD clinics and consultant psychiatrists across the UK who trust Pharmazon HomeCare for specialist prescription fulfilment and patient medication delivery.
Arrange Clinic PartnershipFrequently Asked Questions
Ready to Take the Next Step?
Whether you have just been diagnosed or are already on ADHD medication, Pharmazon HomeCare is here to support your prescription needs with specialist care and reliable home delivery.
Reviewed by Archna Gudka, a GPhC-registered pharmacist with over two decades in the profession, including 18 years in community pharmacy delivering front-line patient care. At Pharmazon HomeCare, an ADHD specialist pharmacy, she has spent the past three years advancing her clinical expertise in the management of neurodevelopmental conditions, with additional specialist training from the UK Adult ADHD Network (UKAAN). Her specialisations include ADHD care, neurodevelopmental support and patient-centred, evidence-based practice. Content is prepared with reference to NICE Guideline NG87 and current UK clinical practice. This page does not constitute medical advice. Always follow the guidance of your prescribing clinician. Next review: December 2026.

